BTI
MED icon

Blue Trust Inc’s Medifast MED Stock Holding History

Blue Trust Inc’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-702
Closed -$15.3K – 2760
2024
Q3 		$15.3K Buy
702
+686
+4,288% +$13.2K ﹤0.01% 2049
2024
Q2 		$613 Buy
+16
New +$426 ﹤0.01% 2597
2024
Q1 		– Sell
-236
Closed -$18K – 2511
2023
Q4 		$18K Buy
236
+159
+206% +$11.1K ﹤0.01% 1335
2023
Q3 		$7K Sell
77
-15
-16% -$1.33K ﹤0.01% 1536
2023
Q2 		$10K Buy
92
+88
+2,200% +$7.83K ﹤0.01% 1308
2023
Q1 		$0 Sell
4
-1
-20% -$111 ﹤0.01% 2502
2022
Q4 		$1K Sell
5
-1
-17% -$116 ﹤0.01% 2085
2022
Q3 		$1K Buy
6
+5
+500% +$716 ﹤0.01% 1956
2022
Q2 		$0 Buy
+1
New +$179 ﹤0.01% 1957

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Blue Trust Inc's MED Position: Q4 2024 in Review

Blue Trust Inc sold out of Medifast (MED) in Q4 2024, closing a stake of 702 shares — an estimated $15.3K sold.

Blue Trust Inc first reported a position in MED in Q2 2022 and held it in 9 quarters. The position peaked at $18K in Q4 2023. 129 funds tracked by Wall St. Rank hold MED as of Q4 2024.

  • Blue Trust Inc reported no remaining Medifast position as of Q4 2024 after selling out during the quarter.
  • Blue Trust Inc sold 702 Medifast shares in Q4 2024, an estimated $15.3K.
  • Blue Trust Inc first reported a position in Medifast in Q2 2022 and held it in 9 quarters.
  • Blue Trust Inc's Medifast position peaked at $18K in Q4 2023.
  • 129 funds tracked by Wall St. Rank held Medifast as of Q4 2024.

Based on Blue Trust Inc's 13F filing for Q4 2024, filed 22 Jan 2025.